Farmakokinetiske interaktionsundersøgelser hos postmenopausale kvinder har vist, at der ikke er interaktion med tamoxifen eller hormonsubstitutionsbehandling (østrogen).
Pharmacokinetic interaction studies in postmenopausal women have demonstrated the absence of any interaction potential with tamoxifen or hormone replacement therapy (oestrogen).